← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2007Last known activity
Jan 21, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 5 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT05225285Lead sponsorPhase 3Jan 21, 2022
- NCT05225285Reponsible party - principal investigatorPhase 3Jan 21, 2022
- NCT05225285Sponsor investigatorPhase 3Jan 21, 2022
- NCT05059106Lead sponsorPhase 2/Phase 3Jun 1, 2021
- NCT05059106Reponsible party - principal investigatorPhase 2/Phase 3Jun 1, 2021
- NCT05133609Reponsible party - principal investigatorPhase 1/Phase 2Jan 15, 2021
- NCT05133609Overall official - principal investigatorPhase 1/Phase 2Jan 15, 2021
- NCT05133609Lead sponsorPhase 1/Phase 2Jan 15, 2021
- NCT02733757CollaboratorPhase 2May 1, 2013
- NCT00533390Study chairPhase 4Jan 1, 2007
Details
- Last known activity
- Jan 21, 2022